Revance Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-4.11-26.074.112.45
Price/Sales ratio
0.700.550.430.36
Earnings per Share (EPS)
$-0.88$-0.14$0.88$1.48

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.22-11.31-6.51-8.92-5.10-4.51-5.82-3.84-3.76-2.29-7.05-4.51
Price/Sales ratio
857.682.77K1.93K4.10K195.261.70K107.2714.1610.123.1718.971.70K
Price/Book Value ratio
1.863.283.284.005.003.124.3916.09106.53-4.90199.685.00
Price/Cash Flow ratio
-5.96-14.92-9.72-11.28-6.98-6.64-9.20-4.97-6.93-3.43-12.99-6.64
Price/Free Cash Flow ratio
-5.29-14.08-9.19-10.98-6.53-6.44-8.99-4.59-6.19-3.32-12.78-6.44
Price/Earnings Growth ratio
-0.551.66-1.23-0.342.920.50-0.160.30-0.240.100.360.50
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%-565%100%100%-2380.55%-24805.81%68.88%69.90%61.02%34.98%65.01%-2380.55%
Operating Profit Margin
-13590.07%-24105.66%-29405%-45963.35%-3824.99%-39820.58%-1782.46%-353.06%-205.30%-135.35%-257.95%-3824.99%
Pretax Profit Margin
-16427.41%-24492%-29756.66%-46025.57%-3742.77%-38602.66%-1857.80%-361.59%-268.33%-138.30%-268.33%-3742.77%
Net Profit Margin
-16427.41%-24492%-29756.66%-46025.57%-3823.22%-37824.93%-1840.71%-368.67%-268.86%-138.43%-268.86%-3823.22%
Effective Tax Rate
-13.33%1.54%1.00%1.27%-2.14%2.01%0.92%-1.96%-0.19%-0.09%-0.19%-2.14%
Return on Assets
-32.68%-26.63%-43.68%-40.78%-62.98%-45.90%-39.16%-53.99%-61.25%-67.71%-61.25%-62.98%
Return On Equity
-35.67%-29.01%-50.41%-44.85%-97.90%-69.27%-75.36%-418.89%-2828.74%213.70%-786.70%-69.27%
Return on Capital Employed
-28.56%-27.41%-47.75%-43.82%-73.37%-54.94%-41.43%-59.21%-53.76%-81.38%-67.55%-73.37%
Liquidity Ratios
Current Ratio
16.8721.099.8013.646.507.237.38N/AN/AN/A4.957.23
Quick Ratio
16.7620.999.7513.646.507.237.283.504.703.284.657.23
Cash ratio
16.7016.743.2313.532.294.175.471.641.431.531.434.17
Days of Sales Outstanding
285.90192.237.33K66.872.64KN/A43.5615.7031.2243.1631.22N/A
Days of Inventory outstanding
N/A225.95N/AN/A0.00N/A449.72158.31129.45109.33144.210.00
Operating Cycle
N/A418.18N/AN/A2.64KN/A493.28174.02160.67152.49151.90N/A
Days of Payables Outstanding
N/A486.11N/AN/A33.2828.42968.71165.3132.1133.1235.7733.28
Cash Conversion Cycle
N/A-67.93N/AN/A2.60K-28.42-475.428.70128.56119.3731.0031.00
Debt Ratios
Debt Ratio
0.010.010.010.00N/AN/A0.250.530.660.890.97N/A
Debt Equity Ratio
0.010.010.010.00N/AN/A0.494.1630.49-2.8345.18N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.320.800.961.550.97N/A
Total Debt to Capitalization
0.010.010.010.00N/AN/A0.330.800.961.540.97N/A
Interest Coverage Ratio
-4.87-60.77-73.15-257.10-3.24KN/A-18.03N/AN/AN/A-20.75-3.24K
Cash Flow to Debt Ratio
-18.71-17.75-17.21-50.93N/AN/A-0.96-0.77-0.50-0.50-0.46N/A
Company Equity Multiplier
1.091.081.151.091.551.501.927.7546.18-3.1546.181.55
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-143.79-185.56-199.42-363.90-27.95-257.04-11.64-2.84-1.46-0.92-1.46-27.95
Free Cash Flow / Operating Cash Flow Ratio
1.121.051.051.021.061.031.021.081.111.031.011.03
Cash Flow Coverage Ratio
-18.71-17.75-17.21-50.93N/AN/A-0.96-0.77-0.50-0.50-0.46N/A
Short Term Coverage Ratio
-18.71-17.75-17.21-50.93N/AN/A-40.23-46.67-39.40-86.63-39.40N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A